Profile: Daya Medicals, Inc. is a developer, manufacturer and distributor of pharmaceuticals, medical diagnostic products & laboratory diagnostic equipment. Our D-Mantoux is formulated on tuberculinum pristinum/derivatum proteinosum purificatum tuberculini-purified protein derivative intracutaneous TB (Mantoux) test technology. It is constituted from multi-drug resistant mycobacterium tuberculosis bacteria. Carvasin™ is our primary care/secondary care patient customized medication. It is formulated with specificity for targeting the individual patients' specific vital aberrations that are etiological factors causing heart attack and stroke.

The company was founded in 1996, has revenues of USD 1-5 Million, has ~10 employees and is ISO 9002 certified.